Skip to search formSkip to main contentSkip to account menu

Orap

Known as: Janssen Brand of Pimozide, Pharmascience Brand of Pimozide, orap [brand name] 
brand name of an antipsychotic drug
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pimozide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Analysis on the reliability assurance program of advanced nuclear power plant operating
The reliability assurance program has been used widely in advanced light water reactor nuclear power plant in recent years. The… 
2012
2012
One patent for Europe
volume 30 number 3 march 2012 nature biotechnology to publish the structure of AVL-292. But it is unconcerned about a recent… 
1995
1995
Un cas d'hyponatrémie sévère sous administration de pimozide (Orap)
Nous rapportons un cas d'intoxication a l'eau avec hyponatremie severe et crises convulsives ayant entraine une chute avec… 
1982
1982
Onychotillomania treated with pimozide (Orap).
A case of onychotillomania in a 70-year-old woman is presented. The disease had persisted for 51/2 years. All her fingernails… 
1980
1980
[Use of pimozide (ORAP) in child psychiatry (author's transl)].
: In a double blind cross-over study, pimozide was tested in 10 children with antisocial behavior. During two months, pimozide… 
1980
1980
[Use of pimozide (ORAP) in child psychiatry (author's transl)].
In a double blind cross-over study, pimozide was tested in 10 children with antisocial behavior. During two months, pimozide was… 
1977
1977
The stress-related emotional lability syndrome. II. A multicentre evaluation of Orap.
: This four-week study included 336 patients aged eleven to 80 years with complaints suggestive of stress-related emotional… 
1977
1977
The stress-related emotional lability syndrome. 1. Definition, psychophysiological mechanisms and a pilot experience with Orap.
: Patients suffering from stress-related emotional lability are in our modern life a common phenomenon. The diagnosis is… 
1977
1977
The stress-related emotional lability syndrome. II. A multicentre evaluation of Orap.
This four-week study included 336 patients aged eleven to 80 years with complaints suggestive of stress-related emotional… 
1976
1976
Application of the neuroleptic pimozide (ORAP-R 6238) for tranquilizer indications in a controlled study.
The effect of the neuroleptic pimozide at doses of 2 mg/day was compared with that of diazepam at doses of 3 x 5 mg. This double… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)